CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
24.49
-1.93 (-7.31%)
At close: Mar 31, 2025, 4:00 PM
25.24
+0.75 (3.08%)
Pre-market: Apr 1, 2025, 5:03 AM EDT

CG Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
257.078.2788.1453.61
Short-Term Investments
484.93179.4155.34-
Cash & Short-Term Investments
742187.67143.4853.61
Cash Growth
295.37%30.80%167.65%-
Other Receivables
0.780.090.30
Receivables
0.780.090.30
Prepaid Expenses
11.436.363.424.8
Total Current Assets
754.21194.12147.2158.41
Property, Plant & Equipment
0.490.490.510.2
Long-Term Deferred Charges
-4.67--
Other Long-Term Assets
0.090.020.030.09
Total Assets
754.8199.3147.7558.69
Accounts Payable
6.523.240.991
Accrued Expenses
14.239.685.121.89
Current Portion of Long-Term Debt
--8.972.94
Current Portion of Leases
0.190.220.190.07
Other Current Liabilities
0.441.120.170.07
Total Current Liabilities
21.3714.2515.435.98
Long-Term Debt
--6.5312.06
Long-Term Leases
0.050.240.260.05
Other Long-Term Liabilities
-0.010.350.35
Total Liabilities
21.4214.5122.5718.44
Common Stock
0.01--0
Additional Paid-In Capital
951.356.843.643.27
Retained Earnings
-217.98-129.94-81.34-45.89
Total Common Equity
733.38-123.1-77.69-42.62
Shareholders' Equity
733.38184.79125.1840.25
Total Liabilities & Equity
754.8199.3147.7558.69
Total Debt
0.240.4615.9415.13
Net Cash (Debt)
741.76187.21127.5438.48
Net Cash Growth
296.21%46.79%231.45%-
Net Cash Per Share
11.8743.2334.0910.54
Filing Date Shares Outstanding
76.2266.643.843.65
Total Common Shares Outstanding
76.155.223.843.65
Working Capital
732.84179.87131.7852.43
Book Value Per Share
9.63-23.57-20.22-11.67
Tangible Book Value
733.38-123.1-77.69-42.62
Tangible Book Value Per Share
9.63-23.57-20.22-11.67
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q